Excretion of chloroquine and desethylchloroquine in human milk.
Open Access
- 1 April 1987
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 23 (4) , 473-476
- https://doi.org/10.1111/j.1365-2125.1987.tb03078.x
Abstract
The excretion of chloroquine and the major metabolite, desethylchloroquine, in breast milk was investigated in eleven lactating mothers following a single oral dose of chloroquine (600 mg base). The average milk to plasma concentration ratio at the 24th hour was 6.6 +/- 2.4 for chloroquine and 1.5 +/- 0.6 for desethylchloroquine in five of the volunteers. In five other volunteers the elimination half-life of chloroquine in milk was 8.8 +/- 4.7 days which was longer than that in saliva (3.9 +/- 1.0 days) from the same volunteers. The maximum daily dose of the drug that the infant can receive from breastfeeding was about 0.7% of the maternal start dose of the drug in malaria chemotherapy. It is, therefore, suggested that it is safe for mothers to breastfeed their infants when undergoing treatment for malaria with chloroquine.This publication has 10 references indexed in Scilit:
- Liquid chromatographic analysis of chloroquine and desethylchloroquine in human plasma, saliva and urineJournal of Chromatography B: Biomedical Sciences and Applications, 1986
- Saliva secretion of chloroquine in manJournal of Pharmacy and Pharmacology, 1986
- Safety of chloroquine in chemosuppression of malaria during pregnancy.BMJ, 1985
- Excretion of hydroxychloroquine in human milk [letter]British Journal of Clinical Pharmacology, 1984
- Pharmacologic considerations of drug use in the lactating mother.1981
- Drug Excretion in Human Breast Milk1,2Clinical Pharmacokinetics, 1980
- Excretion of drugs in human milkAmerican Journal of Health-System Pharmacy, 1974
- DETECTION AND DISTRIBUTION OF CHLOROQUINE METABOLITES IN HUMAN TISSUES1962
- Absorption of Antimalarial Drugs in Human SkinJournal of Investigative Dermatology, 1958
- STUDIES ON THE CHEMOTHERAPY OF THE HUMAN MALARIAS. VI. THE PHYSIOLOGICAL DISPOSITION, ANTIMALARIAL ACTIVITY, AND TOXICITY OF SEVERAL DERIVATIVES OF 4-AMINOQUINOLINE 12Journal of Clinical Investigation, 1948